COMP <GO>
CPIX vs ZYBT // RETURN ON INVESTED CAPITAL (ROIC)
Cumberland Pharmaceuticals Inc. (NASDAQ) VS. Zhengye Biotechnology Holding Limited (Class A) (NASDAQ) • 15-METRIC TALLY: CPIX 8
— ZYBT 2
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CPIX
LAST: $4.31 (+2.13%) • MKT CAP: $63.2M
roic
-16.40%
LAST: $1.34 (+0.75%) • MKT CAP: $63.0M
roic
-22.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPIX VS. ZYBT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPIX | ZYBT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.00% | 20.50% | +64.50 | CPIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -16.40% | -22.30% | +5.90 | CPIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.42% | 2.61% | +4.81 | CPIX | /fcf-yield <GO> |
| Operating Margin | -6.30% | -60.00% | +53.70 | CPIX | /operating-margins <GO> |
| Net Profit Margin | -6.40% | -60.00% | +53.60 | CPIX | /net-margins <GO> |
| Revenue Growth (YoY) | 17.60% | -34.80% | +52.40 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.72 | 1.90 | -1.18 | ZYBT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.7 | 45.1 | -12.40 | ZYBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $63.2M | $63.0M | $198.2K | CPIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPIX REV | ZYBT REV | CPIX GROSS % | ZYBT GROSS % | CPIX FCF | ZYBT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.5M | $16.6M | 85.0% | 20.5% | $4.8M | $1.8M |
| FY 2024 | $37.9M | $25.5M | 82.6% | 49.0% | -$678.6K | $3.8M |
| FY 2023 | $39.6M | — | — | — | $6.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPIX // BETA —
ZYBT // BETA —